Similarly, the dopaminergic system, highlighted in recent studies, indicates that dopamine receptors, particularly DRD2 and DRD3, are upregulated in breast cancer, potentially contributing to tumor growth and progression. The gene discussed is DRD2; the disease is neoplasm.